Lenacapavir has delivered impressive trial results and, in July, it received official backing from the World Health ...
A groundbreaking discovery reveals how HIV integrates its genetic material into human DNA, exposing a key viral vulnerability ...
For more than 20 years, the Duke Consortia for HIV/AIDS Vaccine Development had conducted its groundbreaking research with ...
A groundbreaking deal will make a new HIV prevention drug affordable in over 100 low-income countries, potentially advancing global efforts to end the HIV/Aids epidemic.
Patients with HIV experienced more delayed, interrupted, and less robust sleep and rest-activity rhythms compared with those ...
RK HIV AIDS Research and Care Center and Doctor 365 organized a mega health camp for PM Modi’s birthday, benefiting 75,000 ...
The global flow cytometry market is expected to witness a CAGR of ~9% during the forecast period. High incidence and ...
Lenacapavir, a Long-acting injectable drug used to prevent HIV, will be made available for $40 a year in over 120 low- and middle-income countries, under a new agreement announced this week between ...
5don MSNOpinion
My Patient Is Fighting For His Life — And There’s A Border Patrol Agent Camped Outside His Hospital Room
"Choosing not to fight the immigration policy of this administration is the same as choosing to inflict suffering on others." ...
Organized by Dr. Dharmendra Kumar, President of the Guinness World Record-holder RK HIV AIDS Research and Care Center and Doctor 365, in the constituency of Honorable MP Shri Dinesh Makwana, 75,000 ...
A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in over 100 low and middle-income countries at an affordable price of $40 per ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback